tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LBRX Stock Latest News

LB Pharmaceuticals management to meet with Piper Sandler
The FlyLB Pharmaceuticals management to meet with Piper Sandler
4d ago
LBRX
LB Pharmaceuticals Announces $100 Million Private Placement Financing
PremiumCompany Announcements
LB Pharmaceuticals Announces $100 Million Private Placement Financing
18d ago
8K
LBRX
LB Pharmaceuticals prices 3.31M shares at $21.17 in private placement
PremiumThe Fly
LB Pharmaceuticals prices 3.31M shares at $21.17 in private placement
18d ago
LBRX
LB Pharmaceuticals Advances LB-102 Into Long-Term Phase 3 Safety Study for Schizophrenia
PremiumCompany Announcements
LB Pharmaceuticals Advances LB-102 Into Long-Term Phase 3 Safety Study for Schizophrenia
27d ago
LBRX
LB Pharmaceuticals initiates Phase 2 trial of LB-102
PremiumThe Fly
LB Pharmaceuticals initiates Phase 2 trial of LB-102
28d ago
LBRX
LB Pharmaceuticals Advances LB-102 Into Phase 3, Setting Up a Key Schizophrenia Catalyst for Investors
PremiumCompany AnnouncementsLB Pharmaceuticals Advances LB-102 Into Phase 3, Setting Up a Key Schizophrenia Catalyst for Investors
1M ago
LBRX
LB Pharmaceuticals appoints Pazdera as General Counsel
Premium
The Fly
LB Pharmaceuticals appoints Pazdera as General Counsel
1M ago
LBRX
LB Pharmaceuticals initiated with a Buy at Roth Capital
Premium
The Fly
LB Pharmaceuticals initiated with a Buy at Roth Capital
2M ago
LBRX
LB Pharmaceuticals appoints Ellen Rose as SVP, corporate affairs
PremiumThe Fly
LB Pharmaceuticals appoints Ellen Rose as SVP, corporate affairs
2M ago
LBRX
These 3 Biotech Stocks Can Triple from Current Levels, Say Five-Star Analysts – 12/19/2025
PremiumMarket News
These 3 Biotech Stocks Can Triple from Current Levels, Say Five-Star Analysts – 12/19/2025
2M ago
ANAB
LBRX
LB Pharmaceuticals management to meet with Piper Sandler
PremiumThe Fly
LB Pharmaceuticals management to meet with Piper Sandler
2M ago
LBRX
LB Pharmaceuticals price target raised to $35 from $27 at Stifel
PremiumThe Fly
LB Pharmaceuticals price target raised to $35 from $27 at Stifel
2M ago
LBRX
LB Pharmaceuticals added to Russell 2000, Russell 3000 indices
PremiumThe FlyLB Pharmaceuticals added to Russell 2000, Russell 3000 indices
3M ago
LBRX
LB Pharmaceuticals Expands Lease at One Penn Plaza
Premium
Company Announcements
LB Pharmaceuticals Expands Lease at One Penn Plaza
3M ago
8K
LBRX
LB Pharmaceuticals Appoints New Chief Commercial Officer
Premium
Company Announcements
LB Pharmaceuticals Appoints New Chief Commercial Officer
3M ago
8K
LBRX
LB Pharmaceuticals appoints Kaya Pai Panandiker as CCO
PremiumThe Fly
LB Pharmaceuticals appoints Kaya Pai Panandiker as CCO
3M ago
LBRX
NMRA
LB Pharmaceuticals Reports Strong Q3 and Strategic Progress
PremiumCompany Announcements
LB Pharmaceuticals Reports Strong Q3 and Strategic Progress
3M ago
LBRX
LB Pharmaceuticals reports Q3 EPS (61c) vs ($39.49) last year
PremiumThe Fly
LB Pharmaceuticals reports Q3 EPS (61c) vs ($39.49) last year
4M ago
LBRX
LB Pharmaceuticals appoints Rawls as SVP of Regulatory Affairs
PremiumThe Fly
LB Pharmaceuticals appoints Rawls as SVP of Regulatory Affairs
4M ago
LBRX
Opening Day: Cerebras Systems withdraws IPO filing
PremiumThe FlyOpening Day: Cerebras Systems withdraws IPO filing
5M ago
NP
CBK
Buy Rating for LB Pharmaceuticals Driven by Promising LB-102 and Market Potential
Premium
Ratings
Buy Rating for LB Pharmaceuticals Driven by Promising LB-102 and Market Potential
5M ago
LBRX
LB Pharmaceuticals to present posters on Phase 2 NOVA trial of LB-102
Premium
The Fly
LB Pharmaceuticals to present posters on Phase 2 NOVA trial of LB-102
5M ago
LBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >